Home > Inhibitors & Agonists > Wnt/Notch/Hedgehog > Smoothened (Smo)
Cat. No. Product name CAS No.
DC11785 IHR-1

A novel cell membrane impermeable smoothened antagonist with IC50 of 7.6 nM in Hh-dependent Gli transcriptional activity assay.

548779-60-8
DC11784 IHR-Nac

A novel cell permeable smoothened antagonist with IC50 of 3.1 nM in Hh-dependent Gli transcriptional activity assay.

DC8570 ALLO-1 Featured

ALLO-1 is a SMO antagonist that inhibits both wild-type (IC50 = 50 nM) and mutant SMO, including the D473H SMO mutant (IC50s = 300-1000 nM).

37468-32-9
DC7154 BMS-833923 (XL-139) Featured

BMS 833923 is an orally bioavailable inhibitor of Smo. It blocks binding of BODIPY cyclopamine (IC50 = 21 nM) and inhibits Gli activation in cell lines that express wild-type Smo or activated mutant forms of Smo (IC50s = 6-35 nM). BMS 833923 robustly inhi

1059734-66-5
DC8493 NVP-LDE225(Erismodegib) Featured

LDE225 (NVP-LDE225) is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human), respectively. Phase 3.

956697-53-3
DC7185 LDE225 Diphosphate Featured

LDE225 (NVP-LDE225) is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human), respectively. Phase 3.

1218778-77-8
DC7191 LY-2940680(Taladegib) Featured

LY2940680 binds to the Smoothened (Smo) receptor and potently inhibits Hedgehog (Hh) signaling.

1258861-20-9
DC9707 MK-4101 Featured

MK-4101 is a potent SMO Inhibitor of the Hedgehog Pathway, highly active against Medulloblastoma and Basal Cell Carcinoma.

935273-79-3
DC12288 MRT-83

MRT-83 is a potent antagonist of Smo, with an IC50 in the nanomolar range.

1263131-92-5
DC7027 Glasdegib(PF-04449913) Featured

PF-04449913 is a potent and orally bioavailable inhibitor of smoothened with IC50 of 5 nM(Gli-luciferase reporter reporter in C3H10T1/2); the hedgehog pathway inhibitor

1095173-27-5
DC12373 PF-5274857 Featured

PF-5274857 is a potent and selective Smoothened (Smo) antagonist, inhibits Hedgehog (Hh) signaling with IC50 and Ki of 5.8 nM and 4.6 nM, respectively, and can penetrate the blood–brain barrier.

1373615-35-0
DC7255 Purmorphamine Featured

Purmorphamine, which directly binds and activates Smoothened, blocks BODIPY-cyclopamine binding to Smo with IC50 of ~ 1.5 μM and also is an inducer of osteoblast differentiation with EC50 of 1 μM.

483367-10-8
DC8327 SANT-1 Featured

SANT-1 is a membrane permeable antagonist of the Shh (Sonic Hedgehog) signaling pathway by direct binding to Smo.

304909-07-7
DC12276 Saridegib (IPI-926; Patidegib) Featured

Saridegib is a potent and specific inhibitor of Smoothened (Smo), a key signaling transmembrane protein in the Hedgehog (Hh) pathway.

1037210-93-7
DC8391 Smoothened Agonist (SAG) HCl Featured

Smoothened Agonist (SAG) HCl is a cell-permeable Smoothened (Smo) agonist with EC50 of 3 nM in Shh-LIGHT2 cells.

2095432-58-7
DC4232 Vismodegib (GDC-0449) Featured

Vismodegib (formerly GDC-0449) is a hedgehog antagonist, is also an orally bioavailable small molecule with potential antineoplastic activity.

879085-55-9
DC8225 Smoothened Agonist (SAG) free base Featured

SAG is a potent Smoothened (Smo) receptor agonist (Kd = 59 nM); potently activates the Hedgehog signaling pathway in Shh-light 2 cells (EC50 ~ 3 nM).

912545-86-9
DC40393 SAG dihydrochloride

SAG dihydrochloride is a potent Smoothened (Smo) receptor agonist (EC50=3 nM; Kd=59 nM). SAG dihydrochloride activates the Hedgehog signaling pathway and counteracts Cyclopamine inhibition of Smo.

DC40460 IHR-Cy3

IHR-Cy3 is a potent fluorescent Smo antagonist with an IC50?of 100 nM.

DC47157 KAAD-Cyclopamine

KAAD-Cyclopamine, a hedgehog signaling inhibitor, is a smoothened antagonist.

306387-90-6
DC47944 MRT-81 Featured

MRT-81 is a potent antagonist of human and rodent smoothened Smo receptors, with an IC50 value of 41 nM in the Shh-light2 cells. MRT-81 has potent hedgehog inhibiting activity. MRT-81 can be used for the research of cancer.

1263132-08-6
DC50278 MRT-14

MRT-14 is a potent antagonist of Smo. Smo is the major component involved in signal transduction of the Hedgehog (Hh) morphogens. MRT-14 has the potential for the research of several types of cancers linked to abnormal Hh signaling.

1263131-83-4
Page 1 / Total 2 FirstPrevNextLastGoto